166 related articles for article (PubMed ID: 30891604)
1. Immunogenicity and Safety of an Inactivated Enterovirus 71 Vaccine Administered Simultaneously With Hepatitis B Vaccine and Group A Meningococcal Polysaccharide Vaccine: A Phase 4, Open-Label, Single-Center, Randomized, Noninferiority Trial.
Zhang Z; Liang Z; Zeng J; Zhang J; He P; Su J; Zeng Y; Fan R; Zhao D; Ma W; Zeng G; Zhang Q; Zheng H
J Infect Dis; 2019 Jul; 220(3):392-399. PubMed ID: 30891604
[TBL] [Abstract][Full Text] [Related]
2. Immunogenicity and safety of the inactivated enterovirus 71 vaccine administered concomitantly with the measles-rubella vaccine in infants aged 8 months in China: A noninferiority randomized controlled trial.
Zhao Z; Liao Y; Li Y; Jiang G; Huang Z; Yang H; Ou Z; Yin Q; Chen J; Deng Y; Jiang R; Che Y; Li Q; Zheng H; Zhang J
Vaccine; 2022 Aug; 40(33):4709-4715. PubMed ID: 35753838
[TBL] [Abstract][Full Text] [Related]
3. Interchangeability of two Enterovirus 71 inactivated vaccines in Chinese children: A phase IV, open-label, and randomized controlled trial.
Xu Q; Cao Q; Yang W; Liu X; Liu H; Tian X; Li J; Fang X; Jia N; Zeng G; Xu A
Vaccine; 2020 Mar; 38(12):2671-2677. PubMed ID: 32067817
[TBL] [Abstract][Full Text] [Related]
4. A Phase I, randomized, open-label study to evaluate the safety and immunogenicity of an enterovirus 71 vaccine.
Cheng A; Fung CP; Liu CC; Lin YT; Tsai HY; Chang SC; Chou AH; Chang JY; Jiang RH; Hsieh YC; Su IJ; Chong PC; Hsieh SM
Vaccine; 2013 May; 31(20):2471-6. PubMed ID: 23541623
[TBL] [Abstract][Full Text] [Related]
5. Immunogenicity and reactogenicity of a three-dose primary vaccination course with a combined diphtheria-tetanus-acellular pertussis-hepatitis B-inactivated polio-haemophilus influenzae type b vaccine coadministered with a meningococcal C conjugate vaccine.
Tejedor JC; Omeñaca F; García-Sicilia J; Verdaguer J; Van Esso D; Esporrín C; Molina V; Muro M; Marés J; Enrubia M; Moraga F; García-Corbeira P; Dobbelaere K; Schuerman L;
Pediatr Infect Dis J; 2004 Dec; 23(12):1109-15. PubMed ID: 15626947
[TBL] [Abstract][Full Text] [Related]
6. Immunogenicity and safety of an inactivated enterovirus 71 vaccine co-administered with measles-mumps-rubella vaccine and live-attenuated Japanese encephalitis vaccine: a phase 4, single-center, randomized controlled trial.
Liu X; Yang W; Zhang C; Wu H; Wang R; Ding Q; Hu Y; Xiong Y; Zhang S; Wang L
Hum Vaccin Immunother; 2021 Dec; 17(12):5348-5354. PubMed ID: 34905446
[TBL] [Abstract][Full Text] [Related]
7. The development of a new heptavalent diphtheria-tetanus-whole cell pertussis-hepatitis B-Haemophilus influenzae type b-Neisseria meningitidis serogroups A and C vaccine: a randomized dose-ranging trial of the conjugate vaccine components.
Gatchalian S; Palestroque E; De Vleeschauwer I; Han HH; Poolman J; Schuerman L; Dobbelaere K; Boutriau D
Int J Infect Dis; 2008 May; 12(3):278-88. PubMed ID: 17981067
[TBL] [Abstract][Full Text] [Related]
8. Impact of a birth dose of hepatitis B vaccine on the reactogenicity and immunogenicity of diphtheria-tetanus-acellular pertussis-hepatitis B-inactivated poliovirus-Haemophilus influenzae type b combination vaccination.
Pichichero ME; Blatter MM; Reisinger KS; Harrison CJ; Johnson CE; Steinhoff MC; Senders SD; Rothstein EP; Willems P; Howe BJ
Pediatr Infect Dis J; 2002 Sep; 21(9):854-9. PubMed ID: 12352809
[TBL] [Abstract][Full Text] [Related]
9. Immunogenicity and Safety of an Inactivated Enterovirus 71 Vaccine Administered Simultaneously with Hepatitis B Virus Vaccine, Group A Meningococcal Polysaccharide Vaccine, Measles-Rubella Combined Vaccine and Japanese Encephalitis Vaccine: A Multi-Center, Randomized, Controlled Clinical Trial in China.
Liu X; Chang S; Wang R; Xiao Y; Li F; Xu Q; Zhang S; Chen X; Zhang S; Zhang M; Chen X; Cao Q; Liu X; Wang H; Zhan D; Chen H; Chen W; Jiang J; Zhang C; Wang H; Gao L; Shi X; Yang X; Xu A
Vaccines (Basel); 2022 Jun; 10(6):. PubMed ID: 35746502
[TBL] [Abstract][Full Text] [Related]
10. Induction of immunologic memory by conjugated vs plain meningococcal C polysaccharide vaccine in toddlers: a randomized controlled trial.
MacDonald NE; Halperin SA; Law BJ; Forrest B; Danzig LE; Granoff DM
JAMA; 1998 Nov; 280(19):1685-9. PubMed ID: 9832000
[TBL] [Abstract][Full Text] [Related]
11. Concomitant administration of a fully liquid ready-to-use DTaP-IPV-HB-PRP-T hexavalent vaccine with a meningococcal ACWY conjugate vaccine in toddlers.
Vesikari T; Borrow R; Da Costa X; Thomas S; Eymin C; Boisnard F; Lockhart S
Vaccine; 2018 Dec; 36(52):8019-8027. PubMed ID: 30471953
[TBL] [Abstract][Full Text] [Related]
12. The immunogenicity and safety of a tetravalent measles-mumps-rubella-varicella vaccine when co-administered with conjugated meningococcal C vaccine to healthy children: A phase IIIb, randomized, multi-center study in Italy.
Durando P; Esposito S; Bona G; Cuccia M; Desole MG; Ferrera G; Gabutti G; Pellegrino A; Salvini F; Henry O; Povey M; Marchetti F
Vaccine; 2016 Aug; 34(36):4278-84. PubMed ID: 27423382
[TBL] [Abstract][Full Text] [Related]
13. A randomized, controlled trial to assess the immunogenicity and safety of a heptavalent diphtheria, tetanus, pertussis, hepatitis B, poliomyelitis, hib and meningococcal serogroup C combination vaccine administered at 2, 3, 4 and 12-18 months of age.
Szenborn L; Czajka H; Brzostek J; Konior R; Caubet M; Ulianov L; Leyssen M
Pediatr Infect Dis J; 2013 Jul; 32(7):777-85. PubMed ID: 23838777
[TBL] [Abstract][Full Text] [Related]
14. Safety and immunogenocity of a novel combined Haemophilus influenzae type b-Neisseria meningitidis serogroups A and C-tetanus-toxoid conjugate vaccine in healthy Chinese children aged 6 months to 5 years old.
Hu JL; Tao H; Li JX; Dai WM; Song B; Sun JF; Liu P; Tang J; Liu WY; Wang SY; Zhu FC
Hum Vaccin Immunother; 2015; 11(5):1120-8. PubMed ID: 25833163
[TBL] [Abstract][Full Text] [Related]
15. 2-Year Efficacy, Immunogenicity, and Safety of Vigoo Enterovirus 71 Vaccine in Healthy Chinese Children: A Randomized Open-Label Study.
Wei M; Meng F; Wang S; Li J; Zhang Y; Mao Q; Hu Y; Liu P; Shi N; Tao H; Chu K; Wang Y; Liang Z; Li X; Zhu F
J Infect Dis; 2017 Jan; 215(1):56-63. PubMed ID: 28077584
[TBL] [Abstract][Full Text] [Related]
16. Safety and immunogenicity of a toddler dose following an infant series of a hexavalent diphtheria, tetanus, acellular pertussis, inactivated poliovirus, Haemophilus influenzae type b, hepatitis B vaccine administered concurrently or at separate visits with a heptavalent pneumococcal conjugate vaccine.
Halperin SA; Tapiéro B; Dionne M; Meekison W; Diaz-Mitoma F; Zickler P; Rubin E; Embree J; Bhuyan P; Lee A; Li M; Tomovici A
Pediatr Infect Dis J; 2014 Jan; 33(1):73-80. PubMed ID: 24346596
[TBL] [Abstract][Full Text] [Related]
17. Immunogenicity and safety of the quadrivalent meningococcal ACWY-tetanus toxoid conjugate vaccine (MenACWY-TT) in splenectomized or hyposplenic children and adolescents: Results of a phase III, open, non-randomized study.
Klein NP; Habanec T; Kosina P; Shah NR; Kolhe D; Miller JM; Hezareh M; Van der Wielen M
Vaccine; 2018 Apr; 36(17):2356-2363. PubMed ID: 29576307
[TBL] [Abstract][Full Text] [Related]
18. A randomized study to evaluate the immunogenicity and safety of a heptavalent diphtheria, tetanus, pertussis, hepatitis B, poliomyelitis, haemophilus influenzae b, and meningococcal serogroup C combination vaccine administered to infants at 2, 4 and 12 months of age.
Thollot F; Scheifele D; Pankow-Culot H; Cheuvart B; Leyssen M; Ulianov L; Miller JM
Pediatr Infect Dis J; 2014 Dec; 33(12):1246-54. PubMed ID: 25037033
[TBL] [Abstract][Full Text] [Related]
19. Immunogenicity and safety of a combination diphtheria, tetanus toxoid, acellular pertussis, hepatitis B, and inactivated poliovirus vaccine coadministered with a 7-valent pneumococcal conjugate vaccine and a Haemophilus influenzae type b conjugate vaccine.
Pichichero ME; Bernstein H; Blatter MM; Schuerman L; Cheuvart B; Holmes SJ;
J Pediatr; 2007 Jul; 151(1):43-9, 49.e1-2. PubMed ID: 17586189
[TBL] [Abstract][Full Text] [Related]
20. Comparison of the reactogenicity and immunogenicity of a combined diphtheria, tetanus, acellular pertussis, hepatitis B, inactivated polio (DTPa-HBV-IPV) vaccine, mixed with the Haemophilus influenzae type b (Hib) conjugate vaccine and administered as a single injection, with the DTPa-IPV/Hib and hepatitis B vaccines administered in two simultaneous injections to infants at 2, 4 and 6 months of age.
Arístegui J; Dal-Ré R; Díez-Delgado J; Marés J; Casanovas JM; García-Corbeira P; De Frutos E; Van Esso D; Verdaguer J; De la Flor J; Moraga F; Boceta R; García-Martínez JA
Vaccine; 2003 Sep; 21(25-26):3593-600. PubMed ID: 12922087
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
